Business
FDA expected to approve Pfizer-BioNTech booster shots for 12- to 15-year-olds early next week
“As the booster is already authorized for 16 and over, we are confident that regulators are doing everything they can to look for ways to maintain a high level of protection against the virus across broad populations,” wrote Jerica Pitts, a Pfizer spokeswoman. , in an email.
